The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.
A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well-funded players are racing for market share on a truly global stage.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Key Questions Answered
Will all newborns receive Whole Genome Sequencing at birth?
How fast will Direct to Consumer Testing grow?
What sequencing technology will take the lead?
What's holding the industry back?
Where are the over 800 locations that have high throughput devices?
Key Topics Covered:
1. Introduction and Market Definition 1.1 Whole Genome Sequencing Definition In This Report 1.1.1 Whole and Exome Sequencing 1.1.2 Research and Clinical 1.1.3 Direct to Consumer 1.1.4 AgriBio 1.1.5 Tumor Cells 1.2 The Genomics Revolution 1.3 Market Definition 1.3.1 Revenue Market Size 1.4 U.S. Medical Market and laboratory Testing - Perspective 1.4.1 U.S. Medicare Expenditures for laboratory testing 1.5 Sizing the Genome - Not What You Think 1.5.1 Cost, Price and Genome Size, Pricing Practice
2. Market Overview 2.1 Market Participants Play Different Roles 2.1.1 Instrument Manufacturer 2.1.2 Independent lab specialized/esoteric 2.1.3 Independent lab national/regional 2.1.4 Independent lab analytical 2.1.5 Public National/regional lab 2.1.6 Hospital lab 2.1.7 Physician lab 2.1.8 DTC Lab 2.1.9 Sequencing Labs 2.1.10 Audit body 2.2 Whole Genome Sequencing -Markets, Examples and Discussion 2.2.1 Direct to Consumer - Two Approaches 188.8.131.52 The New Age of Medical Information 184.108.40.206 Dangers in DTC-WGS - Health Costs and Regulation 220.127.116.11 Newborn and Prenatal - A Brave New World 18.104.22.168 DTC - How Many Segments? 2.2.2 Research Markets 22.214.171.124 Research Funding and Capital Expense 126.96.36.199 WGS Datasets Preferred 188.8.131.52 Existing research repurposed 184.108.40.206 Organism Wide Market 220.127.116.11 Service Suppliers Respond 2.2.3 Clinical - Understanding Germline and Somatic 18.104.22.168 Somatic - Chasing Mutations and Pharmacogenomics 2.2.4 Pathogen Testing 22.214.171.124 The Hepatitis C Story 126.96.36.199 Will the Microbiology Department Disappear? 2.2.5 AgriBio - Big Business 188.8.131.52 GMO is Here to Stay 184.108.40.206 WGS Benefits and Risks 220.127.116.11 The New Agriculture 2.3 Industry Structure 2.3.1 Hospital's Testing Share 2.3.2 Economies of Scale 2.3.3 Instrument Manufacturer Role 2.3.4 Healthcare Industry Impacts - Still Struggling 18.104.22.168 Can the Healthcare Industry Adapt? 22.214.171.124 Genetic Counselling as an Industry 126.96.36.199 WGES Adoption and Cannibalization 188.8.131.52 The Meaning of Grail
3. Market Trends 3.1 Factors Driving Growth 3.1.1 Diagnostic Factors 3.1.2 Interpreting the Code Otherwise 3.1.3 Changes in Agriculture. 3.1.4 Fertility Technology Comes of Age 3.1.5 Pathogen Challenges 3.2 Factors Limiting Growth 3.2.1 Increased Competition Lowers Price 3.2.2 Lower Costs 3.2.3 Healthcare Cost Concerns Curtail Growth 3.2.4 Wellness has a downside 3.2.5 GMO Opposition Movement. 3.3 Sequencing Instrumentation 3.3.1 Instrumentation Tenacity. 3.3.2 Declining Cost of Instruments Changes Industry Structure. 3.3.3 Listing of Current NGS Instrument Specifications. 3.3.4 Oxford Nanopore 184.108.40.206 What is Oxford Nanopore Sequencing? 220.127.116.11 What can Oxford Nanopore Sequencingt be used for? 18.104.22.168 Oxford Nanopore Products 3.3.5 Long Reads - Further Segmentation 3.3.6 Linked Reads 3.3.7 Targeted Sequencing Adopts CRISPR 3.3.8 New Sequencing Technologies
4. WGES Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section
UK Whole-Genome Sequencing Project Obtains 200M
WGS may help with disease outbreaks
Veritas Cuts WGS Price by 40%
Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
Machine-learning system used to diagnose genetic diseases
Whole Genome Sequencing for healthy creates controversy